Susquehanna International Group
WVE icon

Susquehanna International Group’s Wave Life Sciences WVE Stock Holding History

Susquehanna International Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Sell
259,825
-119,162
-31% -$1.55M ﹤0.01% 6318
2025
Q4 		$6.44M Buy
378,987
+182,707
+93% +$1.86M ﹤0.01% 3642
2025
Q3 		$1.44M Sell
196,280
-28,146
-13% -$228K ﹤0.01% 6492
2025
Q2 		$1.46M Buy
224,426
+107,337
+92% +$709K ﹤0.01% 6511
2025
Q1 		$946K Buy
117,089
+76,558
+189% +$837K ﹤0.01% 7393
2024
Q4 		$501K Buy
+40,531
New +$541K ﹤0.01% 8657
2024
Q3 		– Sell
-78,048
Closed -$467K – 13170
2024
Q2 		$389K Buy
+78,048
New +$445K ﹤0.01% 8863
2024
Q1 		– Sell
-21,558
Closed -$108K – 13492
2023
Q4 		$109K Sell
21,558
-8,661
-29% -$46.3K ﹤0.01% 11257
2023
Q3 		$174K Buy
30,219
+10,556
+54% +$48.2K ﹤0.01% 10386
2023
Q2 		$71.6K Sell
19,663
-709,925
-97% -$2.87M ﹤0.01% 11166
2023
Q1 		$3.16M Buy
729,588
+409,453
+128% +$1.88M ﹤0.01% 4225
2022
Q4 		$2.24M Buy
320,135
+284,659
+802% +$1.31M ﹤0.01% 4497
2022
Q3 		$128K Buy
+35,476
New +$117K ﹤0.01% 11448
2022
Q1 		– Sell
-16,670
Closed -$40.8K – 14099
2021
Q4 		$52K Buy
16,670
+6,607
+66% +$27.4K ﹤0.01% 12522
2021
Q3 		$49K Sell
10,063
-50,725
-83% -$308K ﹤0.01% 12356
2021
Q2 		$405K Sell
60,788
-13,252
-18% -$86.6K ﹤0.01% 10102
2021
Q1 		$415K Buy
74,040
+62,987
+570% +$605K ﹤0.01% 9900
2020
Q4 		$87K Sell
11,053
-132,050
-92% -$1.11M ﹤0.01% 10562
2020
Q3 		$1.22M Buy
143,103
+6,297
+5% +$69K ﹤0.01% 5650
2020
Q2 		$1.42M Buy
136,806
+65,312
+91% +$615K ﹤0.01% 5137
2020
Q1 		$670K Buy
71,494
+4,238
+6% +$36.1K ﹤0.01% 6299
2019
Q4 		$539K Buy
67,256
+43,926
+188% +$1.08M ﹤0.01% 6847
2019
Q3 		$479K Buy
23,330
+2,707
+13% +$62.1K ﹤0.01% 7399
2019
Q2 		$538K Buy
+20,623
New +$578K ﹤0.01% 7111
2016
Q2 		– Sell
-10,790
Closed -$150K – 9441
2016
Q1 		$150K Buy
+10,790
New +$151K ﹤0.01% 8208

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Susquehanna International Group's WVE Position: Q1 2026 in Review

Susquehanna International Group reduced its Wave Life Sciences (WVE) stake by 31% in Q1 2026, selling an estimated $1.55M and leaving 259,825 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #6318.

Susquehanna International Group first reported a position in WVE in Q1 2016 and has held it in 25 quarters since. The position peaked at $6.44M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Susquehanna International Group held 259,825 shares of Wave Life Sciences worth $1.88M as of Q1 2026.
  • Susquehanna International Group sold 119,162 Wave Life Sciences shares in Q1 2026, an estimated $1.55M.
  • Wave Life Sciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6318 holding.
  • Susquehanna International Group first reported a position in Wave Life Sciences in Q1 2016 and has held it in 25 quarters since.
  • Susquehanna International Group's Wave Life Sciences position peaked at $6.44M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.